Axsome: Alzheimer's Disease Agitation sNDA Adds Optionality, Not A Thesis Changer

Axsome Therapeutics, Inc. remains a Sell due to an undifferentiated CNS pipeline, heavy SG&A and net losses. Learn more about ...